By fusing behavioral data, real-time analytics and generative AI, the industry is entering a new era: attention hacking at ...

Patients with stage 3 colorectal cancer who tested MRD-positive with Signatera after surgery saw a meaningful survival ...

This population-based study used plasma pTau217 to estimate how common Alzheimer’s disease neuropathological changes are ...

The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, ...

Automakers use AI-driven predictive maintenance and computer vision control to achieve a 35-50% reduction in unscheduled ...

Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

New findings suggest blood tests still being assessed are showing promising results for early cancer screenings, especially ...

Adaptive test is starting to gain traction for high-performance computing and AI chips as test programs that rely on static limits and fixed test sequences reach their practical limits.

While I don't think we're there yet, there may be parts of all of this that we can work with to our advantage. Maybe, getting ...

As the world faces a surge of new synthetic chemicals and increasingly complex toxicity patterns, traditional animal testing ...

Its tests aren’t perfect, but they’re better predictors of college performance than anything anyone else is using.